C. Ann Merrifield - 10 Jun 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
Issuer symbol
LYRA
Transactions as of
10 Jun 2022
Net transactions value
+$20,200
Form type
4
Filing time
13 Jun 2022, 16:05:17 UTC
Previous filing
17 May 2022
Next filing
21 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Purchase $20,200 +4,000 +55% $5.05 11,328 10 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.